Khóa luận tốt nghiệp dược sĩ: Tổng quan một số ứng dụng của quang phổ raman trong kiểm nghiệm dược phẩm

g Anh
2. Anil K. Deisingh, (2005), “Pharmaceutical counterfeiting”, Analyst,
130, pp.271-279.
3. Al-Zoubi N, Koundourellis JE, Malamataris S, (2002), “FT-IR and
Raman spectroscopic methods for identification and quantitation of
orthorhombic and monoclinic paracetamol in powder mixes”, Journal
of Pharmaceutical and Biomedical Analysis, 29(3), pp.459–467.
4. Auer

ME.,

GriesserUJ.,Sawatzki

J.

(2003),

“Qualitative

and

quantitative study of polymorphic forms in drug formulations by near
infrared FT-Raman spectroscopy”, Journal of Molecular Structure,
661–662(16), pp.307–317.
5. R. B. Bilhorn, P. M. Epperson, I. V. Sweedler, and M. B. Denton
(1987), "Spectrochemical Measurements with Multichannel Integrating
Detectors", Applied Spectroscopy , 41(7), pp. 1125-1136.
6. Derek A. Long (2002), The Raman Effect: A Unified Treatment of the
Theory of Raman Scattering by Molecules, John Wiley & Sons Ltd,
England.
7. De Spiegeleer B., Seghers D., Wieme R., Schaubroeck J., Verpoort F.,

Slegers G., Van Vooren L. (2005),“Determination of the relative


amounts of three crystal forms of a benzimidazole drug in complex
finished formulations by FT-Raman spectroscopy”J. Pharm. Biomed.
Anal., 39 (1-2), pp. 275–280.
8. Gamberini MC., Baraldi C., Tinti A., Rustichelli C., Ferioli V.,
Gamberini G. (2006), “Solid state characterization of chloramphenicol
palmitate. Raman spectroscopy applied to pharmaceutical polymorphs”,
Journal of Molecular Structure, 785(1–3), pp. 216–224.
9. Hwang MS., Cho S., Chung H., Woo YA.(2005), “Nondestructive
determination
spectroscopy”,

of

theambroxol
Journal

content

in

tablets

by

Raman

of Pharmaceutical and Biomedical

Analysis,38(2), Pp. 210–215.
10. Izolani AO., DeMoraes MT., Tellez CA. (2003), “Fourier transform
Raman spectroscopy of drugs:Quantitative analysis of 1-phenyl-2,3dimethyl-5-Pyrazolone-4-methylaminomethane

sodium

sulfonate

(dipyrone)”, Journal of Raman Spectroscopy, 34(10), pp. 837–843.
11. John R. Ferraro, Kazuo Nakamoto, Chris W. Brown (2003),
Introductory Raman Spectroscopy, Elsevier, America.
12. Lin W-Q, Jiang J-H, Yang H-F, Ozaki Y, Shen G-L, Yu R-Q (2006),
“Characterisation of Chloroamphenicol Palmitate drug polymorphs by
Ramanmapping with multi variate image segmentation using a spatial
directed agglomeration clustering method”, Analytical Chemistry,
78 (17), pp. 6003–6011.
13. McCreery RL, (2000), Raman Spectroscopy for Chemical Analysis,
John Wiley & Sons Ltd, New York.


14. Mazurek S., Szostak R. (2006), “Quantitative determination of
captopril and prednisolone in tablets by FT-Raman spectroscopy”,
Journal of Pharmaceutical and Biomedical Analysis, 40(5), pp. 1225–
1230.
15. Okumura T., Otsuka M. (2005), “Evaluation of the microcrystallinity
of a drug substance, indomethacin, in a pharmaceutical model tablet by
chemometric FT-Raman spectroscopy”, Pharmaceutical Research,
22(8), pp.1350–1357.
16. Pemberton J. E., Sobocinski R. L., Bryant M. A., and Carter D. A.,

(1990), “Raman Spectroscopy Using Charge Coupled Device
Detection”, Spectroscopy, 5(2), pp.26.
17. Pratiwi D., Fawcett JP., Gordon KC., Rades T. (2002),“Quantitative
analysis of polymorphic mixtures of ranitidne hydrochloride by Raman
spectroscopy and principal component analysis”, European Journal of
Pharmaceutics and Biopharmaceutics, 54(3),pp. 337–341.
18. Pelletier MJ (2003), Quantitative analysis using Raman spectrometry.
Applied

Spectroscopy,57,

pp.20A-39A,

Society

for

appied

Spectroscop, England and America.
19. Pushkar P. Kalantri, Rakesh R. Somani, Dinesh T. Makhija (2010),
“Raman

spectroscopy:

A

potential

technique

in

analysis

of

pharmaceuticals”, Der Chemica Sinica, pp.5-8.
20. Pestaner JP., Mullick FG., Centeno JA. (1996), “Characterization of
acetaminophen: molecular microanalysis with Raman microprobe
spectroscopy”, Journal of Forensic Sciences, 41(6).


21. Rantanen J, Wikstrom H, Rhea FE, Taylor LS, (2005), “Improved
understanding

of

factors

contributing

to

quantification

of

anhydrate/hydrate powder mixtures”, Applied Spectroscopy, 59(7), pp.
942–951.

22. Roberts SNC., Williams AC., GrimseyIM., Booth SW. (2002),
“Quantitative

analysis

of

mannitol

polymorphs.

FT-Raman

spectroscopy”, Journal of Pharmaceutical and Biomedical Analysis,
28(6), pp. 1135–1147.
23. Strachan CJ., Pratiwi D., Gordon KC., Rades T. (2004), “Quantitative
analysis of polymorphic mixtures of carbamazepine by Raman
spectroscopy and principal components analysis”,Journal of Raman
Spectroscopy, 35(5), pp. 347–352.
24. Steven E. J. Bell, D. Thorburn Burns, Andrew C. Dennisa and James
S. Speersb, (2000), “Rapid analysis of ecstasy and related
phenethylamines in seized tablets by Raman spectroscopy”, Analyst,
125(3), pp. 541–544.
25. Skoulika SG., Georgiou CA. (2003), “Rapid, noninvasive quantitative
determination of acyclovir in pharmaceutical solid dosage forms
through their poly(vinyl chloride) blister package by solid-state fourier
transform Raman spectroscopy”, Applied Spectroscopy, 57(4).
26. Szostak R, Mazurek S, (2002), “Quantitative determination of
acetylsalicylic acid and acetaminophen in tablets by FT-Raman
spectroscopy”, Analyst, 127, 144–148.

27. Szostak R., Mazurek S. (2004), “FT-Raman quantitative determination
of ambroxol in tablets”, Journal of Molecular Structure, 704(1–3), pp
229-233.


28. Slobodan Šašic (2008), Pharmaceutical applications of Raman
Spectroscopy, John Wiley & Son, Canada.
29. U.S Pharmacopeial Convention 34,(2012), America.
30. Vehring R. (2005), “Red-excitation dispersive Raman spectroscopy is
a

suitable

technique

for

solid-state

analysis

of

respirable

pharmaceutical powders”, Applied Spectroscopy, 59(3), pp. 267-391.
31. Vankeirsbilck T., Vercauteren A., Baeyens W., Van derWeken G.,
Verpoort F., Vergote G., Remon JP. (2002), “Applications of Raman
spectroscopy in pharmaceutical analysis”, TrAC Trends in Analytical
Chemistry, 21(12), pp 869–877.